The high prevalence, incidence and mortality rates of prostate cancer in Tobago would appear to strongly indicate that screening of this population would be justified and could positively impact on mortality.
FREE DAILY AND WEEKLY NEWSLETTERS OFFERED BY CONTENT OF INTEREST
Did you find this article relevant? Subscribe to UroToday-GUOncToday!
The fields of GU Oncology and Urology are advancing rapidly including new treatments, enrolling clinical trials, screening and surveillance recommendations along with updated guidelines. Join us as one of our subscribers who rely on UroToday as their must-read source for the latest news and data on drugs. Sign up today for blogs, video conversations, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.
We consider our approach to be consonant with the recommendations of the EAU (Heidenreich A et al, 2013) and the findings of Hugosson et al, 2014).
Patrick A, Bunker C, Nelson J, Dhir R, Wheeler V, Zmuda J, Richard JR, Belle A, Kuller L. Are you the author?
Tobago Health Studies Office, Scarborough, Tobago, Trinidad & Tobago; Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh, Pittsburgh PA, USA.
Reference: BJU Int. 2014 Jul 21. Epub ahead of print.